Yingjun Ding

1.1k total citations
23 papers, 880 citations indexed

About

Yingjun Ding is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Yingjun Ding has authored 23 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cell Biology. Recurrent topics in Yingjun Ding's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Cell Adhesion Molecules Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Yingjun Ding is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Cell Adhesion Molecules Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Yingjun Ding collaborates with scholars based in China, United States and Sweden. Yingjun Ding's co-authors include Yuhua Liao, Tingting Tang, Xianjun Yu, Xiang Cheng, Rui Yao, Jiang-jiao Xie, Yong Chen, Qingqing Fu, Mengyang Liao and Jing Yuan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Yingjun Ding

22 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjun Ding China 11 496 230 150 136 133 23 880
Jiang-jiao Xie China 11 667 1.3× 221 1.0× 115 0.8× 180 1.3× 97 0.7× 13 939
Kunwu Yu China 17 448 0.9× 282 1.2× 114 0.8× 105 0.8× 41 0.3× 32 818
Yucheng Zhong China 17 402 0.8× 195 0.8× 98 0.7× 89 0.7× 47 0.4× 24 632
Daniel Engelbertsen Sweden 18 674 1.4× 252 1.1× 73 0.5× 170 1.3× 73 0.5× 30 911
Vinod S. Ramgolam United States 11 452 0.9× 234 1.0× 181 1.2× 51 0.4× 103 0.8× 16 825
Malte A. Kluger Germany 12 359 0.7× 171 0.7× 88 0.6× 74 0.5× 86 0.6× 18 783
Xiaojin Sha United States 11 454 0.9× 519 2.3× 107 0.7× 108 0.8× 56 0.4× 15 974
Keiichi Yoshimoto Japan 10 249 0.5× 190 0.8× 117 0.8× 55 0.4× 194 1.5× 14 869
Stacy L. Musone United States 10 347 0.7× 291 1.3× 70 0.5× 141 1.0× 134 1.0× 10 1.0k
Masayuki Ogami Japan 10 420 0.8× 192 0.8× 104 0.7× 214 1.6× 85 0.6× 18 1.0k

Countries citing papers authored by Yingjun Ding

Since Specialization
Citations

This map shows the geographic impact of Yingjun Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Ding more than expected).

Fields of papers citing papers by Yingjun Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjun Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Ding. The network helps show where Yingjun Ding may publish in the future.

Co-authorship network of co-authors of Yingjun Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjun Ding. A scholar is included among the top collaborators of Yingjun Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjun Ding. Yingjun Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baretti, Marina, Yingjun Ding, Rose Parkinson, et al.. (2023). A phase II study of durvalumab (MEDI4736) in combination with a CSF-1R inhibitor (SNDX-6352) following chemotherapy or radio-embolization for patients with intrahepatic cholangiocarcinoma.. Journal of Clinical Oncology. 41(16_suppl). e16217–e16217. 1 indexed citations
2.
Ding, Yingjun, et al.. (2023). 360 MicroRNA-223 facilitates vitiligo progression by targeting FBWX7 in melanocytes of H2O2-induced oxidative damage. Journal of Investigative Dermatology. 143(5). S62–S62.
3.
Jiang, Min, Yang Cai, David Vanderwall, et al.. (2023). Tetraspanin Tspan8 restrains interferon signaling to stabilize intestinal epithelium by directing endocytosis of interferon receptor. Cellular and Molecular Life Sciences. 80(6). 154–154. 8 indexed citations
4.
Fu, Chenying, Jie Wang, Sandeep Pallikkuth, et al.. (2022). EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation. Cellular and Molecular Life Sciences. 79(7). 389–389. 6 indexed citations
5.
Wang, Jie, Jonathan D. Wren, Yingjun Ding, et al.. (2022). EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer. Cancer Letters. 536. 215641–215641. 4 indexed citations
6.
Sun, Ge, Junxiong Chen, Yingjun Ding, et al.. (2021). A Bioinformatics Perspective on the Links Between Tetraspanin-Enriched Microdomains and Cardiovascular Pathophysiology. Frontiers in Cardiovascular Medicine. 8. 630471–630471. 6 indexed citations
7.
Yang, Lin, Guanghai Yang, Yingjun Ding, et al.. (2018). Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro. Journal of Cancer. 9(5). 890–900. 32 indexed citations
8.
He, Jing, Yingjun Ding, Min Feng, et al.. (2013). Characteristics of Sjogren's syndrome in rheumatoid arthritis. Lara D. Veeken. 52(6). 1084–1089. 56 indexed citations
9.
Yang, Lin, et al.. (2012). Management of hypertension induced by sorafenib in advanced renal cell carcinoma. Tumori. 32(5). 380–383. 1 indexed citations
10.
Zhu, Zhengfeng, Jingjing Li, Juan Liu, et al.. (2012). Circulating Th17 cells are not elevated in patients with chronic heart failure. Scandinavian Cardiovascular Journal. 46(5). 295–300. 11 indexed citations
11.
Tang, Tingting, You Seon Song, Yingjun Ding, et al.. (2011). Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. Journal of Lipid Research. 52(5). 1023–1032. 75 indexed citations
12.
Tang, Tingting, Yingjun Ding, Yuhua Liao, et al.. (2010). Defective Circulating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>CD127<sup>low</sup> Regulatory T-cells in Patients with Chronic Heart Failure. Cellular Physiology and Biochemistry. 25(4-5). 451–458. 75 indexed citations
13.
Xu, Yingying, Tingting Tang, Yingjun Ding, et al.. (2010). Improved Cardiac Performance by Rosuvastatin Is Associated With Attenuations in Both Myocardial Tumor Necrosis Factor-α and p38MAP Kinase Activity in Rats After Myocardial Infarction. The American Journal of the Medical Sciences. 340(2). 121–127. 10 indexed citations
14.
Xie, Jiang-jiao, Xianjun Yu, Yuhua Liao, et al.. (2009). Poly (ADP-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in ApoE-/- Mice with Hyperhomocysteinemia. Journal of Atherosclerosis and Thrombosis. 16(5). 641–653. 21 indexed citations
15.
Cheng, Xiang, Xianjun Yu, Yingjun Ding, et al.. (2008). The Th17/Treg imbalance in patients with acute coronary syndrome. Clinical Immunology. 127(1). 89–97. 410 indexed citations
16.
Cheng, Xiang, Yingjun Ding, Chunyan Xia, et al.. (2008). Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure. Journal of Cardiac Failure. 15(2). 158–162. 44 indexed citations
17.
Yu, Xianjun, Xiang Cheng, Jiang-jiao Xie, et al.. (2008). Poly (ADP-ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats. Cardiovascular Drugs and Therapy. 23(2). 121–127. 7 indexed citations
18.
Cheng, Xiang, Yong Chen, Jiang-jiao Xie, et al.. (2008). Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE−/− mice through modulation of Th1/Th2 balance. Journal of Molecular and Cellular Cardiology. 45(2). 168–175. 46 indexed citations
19.
Cheng, Xiang, Yong Chen, Xianjun Yu, et al.. (2008). WITHDRAWN: Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice. International Journal of Cardiology. 139(2). 113–122. 7 indexed citations
20.
Cheng, Xiang, Yuhua Liao, Yong Chen, et al.. (2008). Molecular Mechanisms of Felodipine Suppressing Atherosclerosis in High-Cholesterol-Diet Apolipoprotein E-Knockout Mice. Journal of Cardiovascular Pharmacology. 51(2). 188–195. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang-jiao Xie Breakdown of academic impact, for papers by Kunwu Yu Breakdown of academic impact, for papers by Yucheng Zhong Breakdown of academic impact, for papers by Daniel Engelbertsen Breakdown of academic impact, for papers by Vinod S. Ramgolam Breakdown of academic impact, for papers by Malte A. Kluger Breakdown of academic impact, for papers by Xiaojin Sha Breakdown of academic impact, for papers by Keiichi Yoshimoto Breakdown of academic impact, for papers by Stacy L. Musone Breakdown of academic impact, for papers by Masayuki Ogami
Rankless by CCL
2026